Literature DB >> 35578056

Bone metastasis from glioblastoma: a systematic review.

Michael J Strong1, Sravanthi Koduri1, Jodi A Allison2, Cecilia M Pesavento2, Sebele Ogunsola3, Oludotun Ogunsola1, Timothy J Yee1, Siri Sahib S Khalsa1, Yamaan S Saadeh1, Jacob R Joseph1, Osama N Kashlan1, Paul Park1, Mark E Oppenlander1, Nicholas J Szerlip4.   

Abstract

INTRODUCTION: Glioblastoma (GBM) is a devastating disease with poor overall survival. Despite the common occurrence of GBM among primary brain tumors, metastatic disease is rare. Our goal was to perform a systematic literature review on GBM with osseous metastases and understand the rate of metastasis to the vertebral column as compared to the remainder of the skeleton, and how this histology would fit into our current paradigm of treatment for bone metastases.
METHODS: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant literature search was performed using the PubMed database from 1952 to 2021. Search terms included "GBM", "glioblastoma", "high-grade glioma", "bone metastasis", and "bone metastases".
RESULTS: Of 659 studies initially identified, 67 articles were included in the current review. From these 67 articles, a total of 92 distinct patient case presentations of metastatic glioblastoma to bone were identified. Of these cases, 58 (63%) involved the vertebral column while the remainder involved lesions within the skull, sternum, rib cage, and appendicular skeleton.
CONCLUSION: Metastatic dissemination of GBM to bone occurs. While the true incidence is unknown, workup for metastatic disease, especially involving the spinal column, is warranted in symptomatic patients. Lastly, management of patients with GBM vertebral column metastases can follow the International Spine Oncology Consortium two-step multidisciplinary algorithm for the management of spinal metastases.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bone; Extracranial metastasis; Glioblastoma; Metastases; Spine; Vertebral body

Mesh:

Year:  2022        PMID: 35578056     DOI: 10.1007/s11060-022-04025-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  81 in total

Review 1.  Management of glioblastoma: State of the art and future directions.

Authors:  Aaron C Tan; David M Ashley; Giselle Y López; Michael Malinzak; Henry S Friedman; Mustafa Khasraw
Journal:  CA Cancer J Clin       Date:  2020-06-01       Impact factor: 508.702

2.  SPONGIOBLASTOMA MULTIFORME OF THE BRAIN.

Authors:  L Davis
Journal:  Ann Surg       Date:  1928-01       Impact factor: 12.969

3.  Diffuse vertebral body metastasis from a glioblastoma multiforme: a technetium-99m Sestamibi single-photon emission computerized tomography study.

Authors:  P Beauchesne; C Soler; J F Mosnier
Journal:  J Neurosurg       Date:  2000-11       Impact factor: 5.115

Review 4.  Metastatic glioblastoma: case presentations and a review of the literature.

Authors:  Gauri Kalokhe; Sean A Grimm; James P Chandler; Irene Helenowski; Alfred Rademaker; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

Review 5.  Bone marrow metastasis in astrocytic gliomata.

Authors:  E Hsu; D Keene; E Ventureyra; M A Matzinger; C Jimenez; H S Wang; L Grimard
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.

Authors:  Quinn T Ostrom; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2021-10-05       Impact factor: 13.029

Review 7.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

Review 8.  Extraneural Glioblastoma Multiforme Vertebral Metastasis.

Authors:  C Rory Goodwin; Lydia Liang; Nancy Abu-Bonsrah; Alia Hdeib; Benjamin D Elder; Thomas Kosztowski; Chetan Bettegowda; John Laterra; Peter Burger; Daniel M Sciubba
Journal:  World Neurosurg       Date:  2015-12-15       Impact factor: 2.104

9.  Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.

Authors:  Chae-Yong Kim; Sun Ha Paek; Do-Hyun Nam; Jong-Hee Chang; Yong-Kil Hong; Jeong Hoon Kim; Oh Lyong Kim; Se-Hyuk Kim
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

10.  Extra-neural metastases of malignant gliomas: myth or reality?

Authors:  Patrick Beauchesne
Journal:  Cancers (Basel)       Date:  2011-01-27       Impact factor: 6.639

View more
  1 in total

1.  Glioblastoma: an organ-confined disease?

Authors:  Santiago Cabezas-Camarero; Rebeca Pérez-Alfayate; Miguel J Sotelo
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.